Features February 2014 Issue

Research Shows Diabetes Drug May Also Cut Cancer Risks

Research Shows Diabetes Drug May Also Cut Cancer Risks

Insulin sensitizers appear to be especially effective in helping lower the odds of developing breast cancer.

A Cleveland Clinic-led study of two commonly used diabetes drugs found that one group of medications not only helped reduce diabetes symptoms, but it may cut the risk of cancer, too.

To continue reading this article you must be a paid subscriber.

Subscribe to Heart Advisor

Get the next year of HEART ADVISOR for just $20. That's a savings of $19 off the regular rate.

With your paid subscription you will receive unlimited access to all of our online content. That is over a decade of previous issues from Cleveland Clinic, the hospital rated #1 in cardiac care by U.S. News & World Report - free of charge.

Subscriber Log In

Forgot your password? Click Here.

Already subscribe but haven't registered for all the benefits of the website? Click here.